Situation of multidrug-resistant tuberculosis in the Czech Republic, unusual case study

Multidrug-resistant tuberculosis has been a serious medical and epidemic problem all over the world. Management of patients suffering from multidrug-resistant tuberculosis is complicated and therapy is successful in 60–70% of cases only. Therapeutic strategies recommend the application of standardized or an individual treatment regimen based on the results of susceptibility drug tests for second-line antituberculous drugs. The case study describes treatment for multidrug-resistant tuberculosis with individual drug regimen adjusted according to the results of susceptibility tests. Although smear and culture negativity was reached, course of disease was changed in the seventh year of the individual regimen, the disease progressed and the patient died.